| Literature DB >> 24917902 |
Jun Seok Lee1, Myung Gu Kim2, Seok Min Hong3, Se Young Na1, Jae Yong Byun1, Moon Suh Park1, Seung Geun Yeo1.
Abstract
OBJECTIVES:span> Otitis media (OM) is an infectious disease that affects all age brackets. Aural discharge is a typical symptom, occurring in all subtypes of OM. We have compared the identity and antibiotic sensitivity of bacteria isolated from aural discharges of adults and children with various types of OM, including acute OM (AOM), OM with effusion (OME), chronic OM (COM), and cholesteatomatous OM (CSOM).Entities:
Keywords: Adult; Bacteriology; Children; Otitis media
Year: 2014 PMID: 24917902 PMCID: PMC4050092 DOI: 10.3342/ceo.2014.7.2.79
Source DB: PubMed Journal: Clin Exp Otorhinolaryngol ISSN: 1976-8710 Impact factor: 3.372
Distribution of microorganisms in children (age<16 years) and adults (age≥16 years) with AOM, OME, COM, and CSOM and ear discharge
Values are presented as number (%).
OM, otitis media; AOM, acute OM; CSOM, cholesteatomatous OM; COM, chronic OM; OME, OM with effusion; MSSA, methicillin-susceptible Staphylococcus aureus; SP, Streptococcus pneumpniae; MRSA, methicillin-resistant Staphylococcus aureus; CNS, coagulase-negative staphylococcus aureus; PA, Pseudomonas aeruginosa; MC, Moraxiella catarrhalis.
Differences in the distribution of microorganisms and bacterial detection rates in children (age<16 years) and adults (age≥16 years) with AOM, OME, COM, and CSOM and ear discharge
OM, otitis media; AOM, acute OM; CSOM, cholesteatomatous OM; COM, chronic OM; OME, OM with effusion; MSSA, methicillin-susceptible Staphylococcus aureus; SP, Streptococcus pneumpniae; MRSA, methicillin-resistant Staphylococcus aureus; CNS, coagulase-negative Staphylococcus aureus; PA, Pseudomonas aeruginosa; MC, Moraxiella catarrhalis
*Statistically significant. †Distribution of microorganisms. ‡Bacterial detection rate.
Sensitivity of microorganisms to antibiotics in children and adults with AOM
Values are presented as number of sensitive organisms (%).
AOM, acute otitis media; SPT, septrim (co-trimoxazole); CF, cephalothin; OX, oxacillin; CL, clindamycin; PC, penicillin; EM, erythromycin; VAN, vancomycin; TCP, teicoplanin; CIP, ciprofloxacin; AK, amikacin; GM, gentamicin; TOB, tobramycin; LFX, levofloxacin; AZM, aztreonam; CAZ, ceftazidime; PIP, piperacillin; C, children; A, adults; MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; PA, Pseudomonas aeruginosa.
Sensitivity of microorganisms to antibiotics in children and adults with OME
Values are presented as number of sensitive organisms (%).
OME, otitis media with effusion; SPT, septrim (co-trimoxazole); CF, cephalothin; OX, oxacillin; CL, clindamycin; PC, penicillin; EM, erythromycin; VAN, vancomycin; TCP, teicoplanin; CIP, ciprofloxacin; AK, amikacin; GM, gentamicin; TOB, tobramycin; LFX, levofloxacin; AZM, aztreonam; CAZ, ceftazidime; PIP, piperacillin; C, children; A, adults; MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; PA, Pseudomonas aeruginosa.
Sensitivity of microorganisms to antibiotics in children and adults with COM
Values are presented as number of sensitive organisms (%).
COM, chronic otitis media; SPT, septrim (co-trimoxazole); CF, cephalothin; OX, oxacillin; CL, clindamycin; PC, penicillin; EM, erythromycin; VAN, vancomycin; TCP, teicoplanin; CIP, ciprofloxacin; AK, amikacin; GM, gentamicin; TOB, tobramycin; LFX, levofloxacin; AZM, aztreonam; CAZ, ceftazidime; PIP, piperacillin; C, children; A, adults; MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; PA, Pseudomonas aeruginosa.
Sensitivity of microorganisms to antibiotics in children and adults with CSOM
Values are presented as number of sensitive organisms (%).
CSOM, cholesteatomatous otitis media; SPT, septrim (co-trimoxazole); CF, cephalothin; OX, oxacillin; CL, clindamycin; PC, penicillin; EM, erythromycin; VAN, vancomycin; TCP, teicoplanin; CIP, ciprofloxacin; AK, amikacin; GM, gentamicin; TOB, tobramycin; LFX, levofloxacin; AZM, aztreonam; CAZ, ceftazidime; PIP, piperacillin; C, children; A, adults; MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; PA, Pseudomonas aeruginosa
Fig. 1Changes in the rates of isolation of methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa (PA) in children (C) and adults (A) with otitis media from 2001 to 2010.